BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36170365)

  • 21. Deubiquitinase USP1 influences the dedifferentiation of mouse pancreatic β-cells.
    Francis M; Bhaskar S; Komanduri S; Sheshadri P; Prasanna J; Kumar A
    iScience; 2023 May; 26(5):106771. PubMed ID: 37250303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of USP1 deubiquitinase in the pathogenesis and therapy of cancer.
    Antonenko S; Zavelevich M; Telegeev G
    Acta Biochim Pol; 2023 Jun; 70(2):219-231. PubMed ID: 37331010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective and cell-active inhibitors of the USP1/ UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells.
    Chen J; Dexheimer TS; Ai Y; Liang Q; Villamil MA; Inglese J; Maloney DJ; Jadhav A; Simeonov A; Zhuang Z
    Chem Biol; 2011 Nov; 18(11):1390-400. PubMed ID: 22118673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidin-7(8H)-one derivatives as potent USP1 inhibitors.
    Li H; Liu BJ; Xu J; Song SS; Ba R; Zhang J; Huan XJ; Wang D; Miao ZH; Liu T; He JX; Xiong B
    Eur J Med Chem; 2024 Jun; 275():116568. PubMed ID: 38889606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The USP1/UAF1 complex promotes double-strand break repair through homologous recombination.
    Murai J; Yang K; Dejsuphong D; Hirota K; Takeda S; D'Andrea AD
    Mol Cell Biol; 2011 Jun; 31(12):2462-9. PubMed ID: 21482670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. USP1 promotes the aerobic glycolysis and progression of T-cell acute lymphoblastic leukemia via PLK1/LDHA axis.
    Liu S; Xiang Y; Wang B; Gao C; Chen Z; Xie S; Wu J; Liu Y; Zhao X; Yang C; Yue Z; Wang L; Wen X; Zhang R; Zhang F; Xu H; Zhai X; Zheng H; Zhang H; Qian M
    Blood Adv; 2023 Jul; 7(13):3099-3112. PubMed ID: 36912760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ubiquitin-specific peptidase 1: assessing its role in cancer therapy.
    Huang P; Wang Y; Zhang P; Li Q
    Clin Exp Med; 2023 Nov; 23(7):2953-2966. PubMed ID: 37093451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights into phosphorylation-dependent mechanisms regulating USP1 protein stability during the cell cycle.
    Cotto-Rios XM; Jones MJ; Huang TT
    Cell Cycle; 2011 Dec; 10(23):4009-16. PubMed ID: 22101265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer.
    Simoneau A; Engel JL; Bandi M; Lazarides K; Liu S; Meier SR; Choi AH; Zhang H; Shen B; Martires L; Gotur D; Pham TV; Li F; Gu L; Gong S; Zhang M; Wilker E; Pan X; Whittington DA; Throner S; Maxwell JP; Chen Y; Yu Y; Huang A; Andersen JN; Feng T
    Mol Cancer Ther; 2023 Feb; 22(2):215-226. PubMed ID: 36228090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. USP1 promotes cholangiocarcinoma progression by deubiquitinating PARP1 to prevent its proteasomal degradation.
    Zhang DY; Zhu Y; Wu Q; Ma S; Ma Y; Shen ZC; Wang Z; Sun W; Zhou YC; Wang D; Zhou S; Liu Z; Kwong LN; Lu Z
    Cell Death Dis; 2023 Oct; 14(10):669. PubMed ID: 37821462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells.
    Antonenko SV; Telegeev GD
    Exp Oncol; 2020 Jun; 42(2):109-114. PubMed ID: 32602291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity for deubiquitination of monoubiquitinated FANCD2 is driven by the N-terminus of USP1.
    Arkinson C; Chaugule VK; Toth R; Walden H
    Life Sci Alliance; 2018 Oct; 1(5):e201800162. PubMed ID: 30456385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cheminformatics models based on machine learning approaches for design of USP1/UAF1 abrogators as anticancer agents.
    Wahi D; Jamal S; Goyal S; Singh A; Jain R; Rana P; Grover A
    Syst Synth Biol; 2015 Jun; 9(1-2):33-43. PubMed ID: 25972987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two nuclear localization signals in USP1 mediate nuclear import of the USP1/UAF1 complex.
    Garcia-Santisteban I; Zorroza K; Rodriguez JA
    PLoS One; 2012; 7(6):e38570. PubMed ID: 22701671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel role for the deubiquitinase USP1 in the control of centrosome duplication.
    Jung JK; Jang SW; Kim JM
    Cell Cycle; 2016; 15(4):584-92. PubMed ID: 26822809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A genome-wide CRISPR screen identifies USP1 as a novel regulator of the mammalian circadian clock.
    Hu Y; Li X; Zhang J; Liu D; Lu R; Li JD
    FEBS J; 2024 Feb; 291(3):445-457. PubMed ID: 37909373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. USP1 Is Required for Replication Fork Protection in BRCA1-Deficient Tumors.
    Lim KS; Li H; Roberts EA; Gaudiano EF; Clairmont C; Sambel LA; Ponnienselvan K; Liu JC; Yang C; Kozono D; Parmar K; Yusufzai T; Zheng N; D'Andrea AD
    Mol Cell; 2018 Dec; 72(6):925-941.e4. PubMed ID: 30576655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses.
    Liang Q; Dexheimer TS; Zhang P; Rosenthal AS; Villamil MA; You C; Zhang Q; Chen J; Ott CA; Sun H; Luci DK; Yuan B; Simeonov A; Jadhav A; Xiao H; Wang Y; Maloney DJ; Zhuang Z
    Nat Chem Biol; 2014 Apr; 10(4):298-304. PubMed ID: 24531842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of Deubiquitinase USP1 Blocks Pancreatic β-Cell Apoptosis by Inhibiting DNA Damage Response.
    Gorrepati KDD; Lupse B; Annamalai K; Yuan T; Maedler K; Ardestani A
    iScience; 2018 Mar; 1():72-86. PubMed ID: 30227958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis.
    Ma A; Tang M; Zhang L; Wang B; Yang Z; Liu Y; Xu G; Wu L; Jing T; Xu X; Yang S; Liu Y
    Oncogene; 2019 Mar; 38(13):2405-2419. PubMed ID: 30531833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.